Resources

The Business Of Science

Today marks an important milestone for HotSpot Therapeutics as we announce our Series B financing, but it also marks a milestone for me personally – 20 years in the business of biotech. This blog was written by Jonathan Montagu, CEO and co-founder of...

read more

10 Daily (Australia): Statements From FHD, DHHS And AMA

Statements From Federal Health Department, DHHS and AMA regarding PPE shortages: Federal Health Department While not routinely being made available, as they have been traditionally a core area held by states and territories for their needs, gowns and gloves have been...

read more

Biotech CEOs Share Ideas for Coping With Coronavirus

When the pandemic struck, biotechnology chief executives suddenly faced questions about how to keep their workers safe, their research moving and their budgets intact. Read more. The post Biotech CEOs Share Ideas for Coping With Coronavirus appeared first on Atlas...

read more

Running Rehab: Managing Talent In A Pandemic

What a difference a little time makes. When Bruce originally encouraged me to be a contributor to From The Trenches, life was “the way it used to be.” And as Atlas’ Head of Talent, I mused about writing on topics related to Executive Search,...

read more

Accent Therapeutics nabs $63M for RNA cancer push

Two years ago, Accent Therapeutics got off a $40 million series A to target RNA-modifying proteins in cancer; now, in the middle of a pandemic, it’s still managed to bring in a respectable $63 million second funding round. Read more. The post Accent Therapeutics...

read more

Reflections of an Immigrant CEO

When I discussed the topic of writing about my experience as an immigrant biotech CEO with Bruce Booth, I had not yet imagined how the global COVID-19 pandemic would change our lives. I initially hesitated to submit it, now that we are in the midst of this...

read more